Advertisement

Benign and malignant mimickers of infiltrative hepatocellular carcinoma: tips and tricks for differential diagnosis on CT and MRI

  • Federica Vernuccio
    Correspondence
    Corresponding author at: University of Palermo, Via del Vespro, 129, 90127 Palermo, Italy.
    Affiliations
    Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy

    University Paris Diderot, Sorbonne Paris Cité, Paris, France

    I.R.C.C.S. Centro Neurolesi Bonino Pulejo, Contrada Casazza, SS113, 98124 Messina, Italy

    Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University Hospital of Palermo, Via del Vespro 129, 90127 Palermo, Italy
    Search for articles by this author
  • Giorgia Porrello
    Affiliations
    Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University Hospital of Palermo, Via del Vespro 129, 90127 Palermo, Italy
    Search for articles by this author
  • Roberto Cannella
    Affiliations
    Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy

    Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University Hospital of Palermo, Via del Vespro 129, 90127 Palermo, Italy
    Search for articles by this author
  • Laura Vernuccio
    Affiliations
    U.O.C. Geriatria e Lungodegenza, AOUP University Hospital Palermo, CDCD Geriatria, Palermo, Italy
    Search for articles by this author
  • Massimo Midiri
    Affiliations
    Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University Hospital of Palermo, Via del Vespro 129, 90127 Palermo, Italy
    Search for articles by this author
  • Lydia Giannitrapani
    Affiliations
    Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy
    Search for articles by this author
  • Maurizio Soresi
    Affiliations
    Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy
    Search for articles by this author
  • Giuseppe Brancatelli
    Affiliations
    Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University Hospital of Palermo, Via del Vespro 129, 90127 Palermo, Italy
    Search for articles by this author

      Highlights

      • Infiltrative HCC appears as an ill-defined large mass with variable enhancement.
      • Portal vein tumor thrombosis appears as enhancing thrombus close to the main tumor.
      • Diagnosis of infiltrative HCC and neoplastic thrombosis may be challenging.
      • Many benign and malignant lesions may mimic infiltrative HCC and tumor thrombosis.

      Abstract

      Hepatocellular carcinoma (HCC) may have an infiltrative appearance in about 8–20% of cases. Infiltrative HCC can be a challenging diagnosis and it is associated with the worst overall survival among HCC patients. Infiltrative HCC is characterized by the spread of multiple minute nodules throughout the liver, without a dominant one, ultimately resulting into macrovascular invasion. On CT and MRI, infiltrative HCC appears as an ill-defined, large mass, with variable degree of enhancement, and satellite neoplastic nodules in up to 52% of patients. On MRI, it may show restriction on diffusion weighted imaging, hyperintensity on T2- and hypointensity on T1-weighted images, and, if hepatobiliary agent is used, hypointensity on hepatobiliary phase. Infiltrative HCC must be differentiated from other liver diseases, such as focal confluent fibrosis, steatosis, amyloidosis, vascular disorders of the liver, cholangiocarcinoma, and diffuse metastatic disease. In cirrhotic patients, the identification of vascular tumor invasion of the portal vein and its differentiation from bland thrombosis is of utmost importance for patient management. On contrast enhanced CT and MRI, portal vein tumor thrombosis appears as an enhancing thrombus within the portal vein, close to the main tumor and results into vein enlargement. The aim of this pictorial review is to show CT and MRI features that allow the diagnosis of infiltrative HCC and portal vein tumor thrombosis. A particular point of interest includes the tips and tricks for differential diagnosis with potential mimickers of infiltrative HCC.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Imaging
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Siegel R.L.
        • Miller K.D.
        • Jemal A.
        Cancer statistics, 2019.
        CA Cancer J Clin. 2019; 69: 7-34
        • Ferlay J.
        • Soerjomataram I.
        • Ervik M.
        • Dikshit R.
        • Eser S.
        • Mathers C.
        • et al.
        GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11.
        International Agency for Research on Cancer, Lyon, France2013
        • Trevisani F.
        • Caraceni P.
        • Bernardi M.
        • D’Intino P.E.
        • Arienti V.
        • Amorati P.
        • et al.
        Gross pathologic types of hepatocellular carcinoma in Italian patients. Relationship with demographic, environmental, and clinical factors.
        Cancer. 1993; 72: 1557-1563
        • Kojiro M.
        Histopathology of liver cancers.
        Best Pract Res Clin Gastroenterol. 2005; 19: 39-62
        • He J.
        • Shi J.
        • Fu X.
        • Mao L.
        • Zhou T.
        • Qiu Y.
        • et al.
        The clinicopathologic and prognostic significance of gross classification on solitary hepatocellular carcinoma after hepatectomy.
        Medicine (Baltimore). 2015; 94 (Aug): e1331https://doi.org/10.1097/MD.0000000000001331
        • Yopp A.C.
        • Mokdad A.
        • Zhu H.
        • Mansour J.C.
        • Balch G.C.
        • Choti M.A.
        • et al.
        Infiltrative hepatocellular carcinoma: natural history and comparison with multifocal, nodular hepatocellular carcinoma.
        Ann Surg Oncol. 2015; 22: S1075-S1082https://doi.org/10.1245/s10434-015-4786-7
        • Demirjian A.
        • Peng P.
        • Geschwind J.F.
        • Cosgrove D.
        • Schutz J.
        • Kamel I.R.
        • et al.
        Infiltrating hepatocellular carcinoma: seeing the tree through the forest.
        J Gastrointest Surg. 2011; 15: 2089-2097https://doi.org/10.1007/s11605-011-1614-7
        • Dendy M.S.
        • Camacho J.C.
        • Ludwig J.M.
        • Krasinskas A.M.
        • Knechtle S.J.
        • Kim H.S.
        Infiltrative hepatocellular carcinoma with portal vein tumor thrombosis treated with a single high-dose Y90 radioembolization and subsequent liver transplantation without a recurrence.
        Transplant Direct. 2017; 3: e206https://doi.org/10.1097/TXD.0000000000000707
        • Benvegnù L.
        • Noventa F.
        • Bernardinello E.
        • Pontisso P.
        • Gatta A.
        • Alberti A.
        Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development.
        Gut. 2001; 48: 110-115https://doi.org/10.1136/gut.48.1.110
        • Reynolds A.R.
        • Furlan A.
        • Fetzer D.T.
        • Sasatomi E.
        • Borhani A.A.
        • Heller M.T.
        • et al.
        Infiltrative hepatocellular carcinoma: what radiologists need to know.
        Radiographics. 2015; 35: 371-386https://doi.org/10.1148/rg.352140114
        • Kneuertz P.J.
        • Demirjian A.
        • Firoozmand A.
        • Corona-Villalobos C.
        • Bhagat N.
        • Herman J.
        • et al.
        Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes.
        Ann Surg Oncol. 2012; 19: 2897-2907https://doi.org/10.1245/s10434-012-2336-0
        • EASL - European Association for the Study of the Liver
        Clinical practice guidelines: management of hepatocellular carcinoma.
        J Hepatol. 2018; 69 ([Erratum in: J Hepatol. 2019;70:817]): 182-236https://doi.org/10.1016/j.jhep.2018.03.019
        • Canellas R.
        • Mehrkhani F.
        • Patino M.
        • Kambadakone A.
        • Sahani D.
        Characterization of portal vein thrombosis (neoplastic versus bland) on CT images using software-based texture analysis and Thrombus density (Hounsfield units).
        Am J Roentgenol. 2016; 207: W81-W87https://doi.org/10.2214/AJR.15.15928
        • Sherman C.B.
        • Behr S.
        • Dodge J.L.
        • Roberts J.P.
        • Yao F.Y.
        • Mehta N.
        Distinguishing tumor from bland portal vein Thrombus in liver transplant candidates with hepatocellular carcinoma: the A-VENA criteria.
        Liver Transpl. 2019; 25: 207-216https://doi.org/10.1002/lt.25345
        • Lopez Jr., R.R.
        • Pan S.H.
        • Hoffman A.L.
        • Ramirez C.
        • Rojter S.E.
        • Ramos H.
        • et al.
        Comparison of transarterial chemoembolization in patients with unresectable, diffuse vs focal hepatocellular carcinoma.
        Arch Surg. 2002; 137 (discussion 657-8): 653-657
        • Heimbach J.K.
        • Kulik L.M.
        • Finn R.S.
        • Sirlin C.B.
        • Abecassis M.M.
        • Roberts L.R.
        • et al.
        AASLD guidelines for the treatment of hepatocellular carcinoma.
        Hepatology. 2018; 67: 358-380https://doi.org/10.1002/hep.29086
        • Sposito C.
        • Mazzaferro V.
        The SIRveNIB and SARAH trials, radioembolization vs. sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future.
        Hepatobiliary Surg Nutr. 2018; 7: 487-489https://doi.org/10.21037/hbsn.2018.10.06
        • Spreafico C.
        • Sposito C.
        • Vaiani M.
        • Cascella T.
        • Bhoori S.
        • Morosi C.
        • et al.
        Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
        J Hepatol. 2018; 68: 724-732https://doi.org/10.1016/j.jhep.2017.12.026
        • Finn R.S.
        • Qin S.
        • Ikeda M.
        • Galle P.R.
        • Ducreux M.
        • Kim T.Y.
        • et al.
        Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.
        N Engl J Med. 2020; 382: 1894-1905https://doi.org/10.1056/NEJMoa1915745
        • Assalino M.
        • Terraz S.
        • Grat M.
        • Lai Q.
        • Vachharajani N.
        • Gringeri E.
        • et al.
        Liver transplantation for hepatocellular carcinoma after successful treatment of macrovascular invasion - a multi-center retrospective cohort study.
        Transpl Int. 2020; 33: 567-575https://doi.org/10.1111/tri.13586
        • Mei J.
        • Li S.H.
        • Wang Q.X.
        • Lu L.H.
        • Ling Y.H.
        • Zou J.W.
        • et al.
        Resection vs. Sorafenib for hepatocellular carcinoma with macroscopic vascular invasion: a real world, propensity score matched analytic study.
        Front Oncol. 2020; 10: 573https://doi.org/10.3389/fonc.2020.00573
        • Lee S.
        • Kim S.S.
        • Roh Y.H.
        • Choi J.Y.
        • Park M.S.
        • Kim M.J.
        Diagnostic performance of CT/MRI liver imaging reporting and data system v2017 for hepatocellular carcinoma: a systematic review and meta-analysis.
        Liver Int. 2020; 40: 1488-1497
        • Kanematsu M.
        • Semelka R.C.
        • Leonardou P.
        • Mastropasqua M.
        • Lee J.K.
        Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations.
        J Magn Reson Imaging. 2003; 18: 189-195https://doi.org/10.1002/jmri.10336
        • Kim Y.K.
        • Han Y.M.
        • Kim C.S.
        Comparison of diffuse hepatocellular carcinoma and intrahepatic cholangiocarcinoma using sequentially acquired gadolinium-enhanced and Resovist-enhanced MRI.
        Eur J Radiol. 2009; 70: 94-100
        • Park Y.S.
        • Lee C.H.
        • Kim B.H.
        • Lee J.
        • Choi J.W.
        • Kim K.A.
        • et al.
        Using Gd-EOB-DTPA-enhanced 3-T MRI for the differentiation of infiltrative hepatocellular carcinoma and focal confluent fibrosis in liver cirrhosis.
        Magn Reson Imaging. 2013; 31: 1137-1142https://doi.org/10.1016/j.mri.2013.01.011
        • Lim S.
        • Kim Y.K.
        • Park H.J.
        • Lee W.J.
        • Choi D.
        • Park M.J.
        Infiltrative hepatocellular carcinoma on gadoxetic acid-enhanced and diffusion-weighted MRI at 3.0T.
        J Magn Reson Imaging. 2014; 39: 1238-1245https://doi.org/10.1002/jmri.24265
        • Thian Y.L.
        • Low A.S.
        • Chow P.K.
        • Ooi L.L.
        • Chung A.Y.
        • Low S.C.
        • et al.
        Atypical enhancement pattern of hepatocellular carcinoma with portal vein thrombosis on multiphasic CT.
        Ann Acad Med Singapore. 2011; 40: 454-459
        • Danila M.
        • Sporea I.
        • Popescu A.
        • Șirli R.
        Portal vein thrombosis in liver cirrhosis - the added value of contrast enhanced ultrasonography.
        Med Ultrason. 2016; 18: 218-233https://doi.org/10.11152/mu.2013.2066.182.pvt
        • Rosenkrantz A.B.
        • Lee L.
        • Matza B.W.
        • Kim S.
        Infiltrative hepatocellular carcinoma: comparison of MRI sequences for lesion conspicuity.
        Clin Radiol. 2012; 67: e105-e111https://doi.org/10.1016/j.crad.2012.08.019
        • Raab B.W.
        The thread and streak sign.
        Radiology. 2005; 236: 284-285https://doi.org/10.1148/radiol.2361030114
        • Tublin M.E.
        • Dodd 3rd, G.D.
        • Baron R.L.
        Benign and malignant portal vein thrombosis: differentiation by CT characteristics.
        AJR Am J Roentgenol. 1997; 168: 719-723https://doi.org/10.2214/ajr.168.3.9057522
        • Piscaglia F.
        • Gianstefani A.
        • Ravaioli M.
        • Golfieri R.
        • Cappelli A.
        • Giampalma E.
        • et al.
        Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation.
        Liver Transpl. 2010; 16: 658-667https://doi.org/10.1002/lt.22044
        • Margini C.
        • Berzigotti A.
        Portal vein thrombosis: the role of imaging in the clinical setting.
        Dig Liver Dis. 2017; 49: 113-120https://doi.org/10.1016/j.dld.2016.11.013
        • Choi J.Y.
        • Lee J.M.
        • Sirlin C.B.
        CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.
        Radiology. 2014; 273: 30-50https://doi.org/10.1148/radiol.14132362
        • Yu N.C.
        • Chaudhari V.
        • Raman S.S.
        • Lassman C.
        • Tong M.J.
        • Busuttil R.W.
        • et al.
        CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis.
        Clin Gastroenterol Hepatol. 2011; 9: 161-167https://doi.org/10.1016/j.cgh.2010.09.017
        • Bae J.S.
        • Lee J.M.
        • Yoon J.H.
        • Jang S.
        • Chung J.W.
        • Lee K.B.
        • et al.
        How to best detect portal vein tumor thrombosis in patients with hepatocellular carcinoma meeting the Milan criteria: gadoxetic acid-enhanced MRI versus contrast-enhanced CT.
        Liver Cancer. 2020; 9: 293-307https://doi.org/10.1159/000505191
        • van der Pol C.B.
        • Lim C.S.
        • Sirlin C.B.
        • et al.
        Accuracy of the liver imaging reporting and data system in computed tomography and magnetic resonance image analysis of hepatocellular carcinoma or overall malignancy-a systematic review.
        Gastroenterology. 2019; 156: 976-986
        • Brancatelli G.
        • Baron R.L.
        • Federle M.P.
        • Sparacia G.
        • Pealer K.
        Focal confluent fibrosis in cirrhotic liver: natural history studied with serial CT.
        AJR Am J Roentgenol. 2009; 192: 1341-1347https://doi.org/10.2214/AJR.07.2782
        • Bruix J.
        • Sherman M.
        American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update.
        Hepatology. 2011; 53: 1020-1022https://doi.org/10.1002/hep.24199
        • Ryder S.D.
        • Beckingham I.J.
        ABC of diseases of liver, pancreas, and biliary system: acute hepatitis.
        BMJ. 2001; 322: 151-153https://doi.org/10.1136/bmj.322.7279.151
        • Park S.J.
        • Kim J.D.
        • Seo Y.S.
        • Park B.J.
        • Kim M.J.
        • Um S.H.
        • et al.
        Computed tomography findings for predicting severe acute hepatitis with prolonged cholestasis.
        World J Gastroenterol. 2013; 19: 2543-2549https://doi.org/10.3748/wjg.v19.i16.2543
        • Murakami T.
        • Baron R.L.
        • Peterson M.S.
        Liver necrosis and regeneration after fulminant hepatitis: pathologic correlation with CT and MR findings.
        Radiology. 1996; 198: 239-242https://doi.org/10.1148/radiology.198.1.8539386
        • Onishi H.
        • Theisen D.
        • Zachoval R.
        • Reiser M.F.
        • Zech C.J.
        Intrahepatic diffuse periportal enhancement patterns on hepatobiliary phase gadoxetate disodium-enhanced liver MR images: do they correspond to periportal hyperintense patterns on T2-weighted images?.
        Medicine (Baltimore). 2019; 98e14784https://doi.org/10.1097/MD.0000000000014784
        • Martin D.R.
        • Seibert D.
        • Yang M.
        • Salman K.
        • Frick M.P.
        Reversible heterogeneous arterial phase liver perfusion associated with transient acute hepatitis: findings on gadolinium-enhanced MRI.
        J Magn Reson Imaging. 2004; 20: 838-842https://doi.org/10.1002/jmri.20192
        • Marzola P.
        • Maggioni F.
        • Vicinanza E.
        • Daprà M.
        • Cavagna F.M.
        Evaluation of the hepatocyte-specific contrast agent gadobenate dimeglumine for MR imaging of acute hepatitis in a rat model.
        J Magn Reson Imaging. 1997; 7: 147-152https://doi.org/10.1002/jmri.1880070121
        • Dioguardi Burgio M.
        • Bruno O.
        • Agnello F.
        • Torrisi C.
        • Vernuccio F.
        • Cabibbo G.
        • et al.
        The cheating liver: imaging of focal steatosis and fatty sparing.
        Expert Rev Gastroenterol Hepatol. 2016; 10: 671-678https://doi.org/10.1586/17474124.2016.1169919
        • Karaosmanoğlu A.D.
        • Onur M.R.
        • Saini S.
        • Taberi A.
        • Karcaaltincaba M.
        Imaging of hepatobiliary involvement in sarcoidosis.
        Abdom Imaging. 2015; 40: 3330-3337https://doi.org/10.1007/s00261-015-0533-6
        • Ganeshan D.
        • Menias C.O.
        • Lubner M.G.
        • Pickhardt P.J.
        • Sandrasegaran K.
        • Bhalla S.
        Sarcoidosis from head to toe: what the radiologist needs to know.
        Radiographics. 2018; 38: 1180-1200https://doi.org/10.1148/rg.2018170157
        • Jung G.
        • Brill N.
        • Poll L.W.
        • Koch J.A.
        • Wettstein M.
        MRI of hepatic sarcoidosis: large confluent lesions mimicking malignancy.
        AJR Am J Roentgenol. 2004; 183: 171-173https://doi.org/10.2214/ajr.183.1.1830171
        • Masuda K.
        • Takenaga S.
        • Morikawa K.
        • Kano A.
        • Ojiri H.
        Hepatic sarcoidosis with atypical radiological manifestations: a case report.
        Radiol Case Rep. 2018; 13: 936-939https://doi.org/10.1016/j.radcr.2018.06.013
        • Kim S.H.
        • Han J.K.
        • Lee K.H.
        • Won H.J.
        • Kim K.W.
        • Kim J.S.
        • et al.
        Abdominal amyloidosis: spectrum of radiological findings.
        Clin Radiol. 2003; 58: 610-620https://doi.org/10.1016/s0009-9260(03)00142-9
        • DeLeve L.D.
        • Valla D.C.
        • Garcia-Tsao G.
        • American Association for the Study Liver Diseases
        Vascular disorders of the liver.
        Hepatology. 2009; 49: 1729-1764https://doi.org/10.1002/hep.22772
        • Dohan A.
        • Vargas O.
        • Dautry R.
        • et al.
        MR imaging features of focal liver lesions in Wilson disease.
        Abdom Radiol (NY). 2016; 41: 1811-1824
        • Cheon J.E.
        • Kim I.O.
        • Seo J.K.
        • et al.
        Clinical application of liver MR imaging in Wilson’s disease.
        Korean J Radiol. 2010; 11: 665-672
        • Regenboog M.
        • Bohte A.E.
        • Somers I.
        • van Delden O.M.
        • Maas M.
        • Hollak C.E.
        Imaging characteristics of focal splenic and hepatic lesions in type 1 Gaucher disease.
        Blood Cells Mol Dis. 2016; 60: 49-57
        • Razek A.A.K.A.
        • Abdalla A.
        • Barakat T.
        • El-Taher H.
        • Ali K.
        Assessment of the liver and spleen in children with Gaucher disease type I with diffusion-weighted MR imaging.
        Blood Cells Mol Dis. 2018; 68: 139-142
        • Kishnani P.S.
        • Austin S.L.
        • Abdenur J.E.
        • et al.
        Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics.
        Genet Med. 2014; 16: e1
        • Chen Z.Y.
        • Liu Y.P.
        • Zheng G.J.
        Computed tomography and magnetic resonance imaging features of primary and secondary hepatic glycogenosis.
        Ann Hepatol. 2018; 17: 903-905
        • Valla D.C.
        Budd-Chiari syndrome/hepatic venous outflow tract obstruction.
        Hepatol Int. 2018; 12: 168-180https://doi.org/10.1007/s12072-017-9810-5
        • Buscarini E.
        • Gandolfi S.
        • Alicante S.
        • Londoni C.
        • Manfredi G.
        Liver involvement in hereditary hemorrhagic telangiectasia.
        Abdom Radiol (NY). 2018; 43: 1920-1930https://doi.org/10.1007/s00261-018-1671-4
        • Wu J.S.
        • Saluja S.
        • Garcia-Tsao G.
        • Chong A.
        • Henderson K.J.
        • White Jr., R.I.
        Liver involvement in hereditary hemorrhagic telangiectasia: CT and clinical findings do not correlate in symptomatic patients.
        AJR Am J Roentgenol. 2006; 187: W399-W405https://doi.org/10.2214/AJR.05.1068
        • Brancatelli G.
        • Vilgrain V.
        • Federle M.P.
        • Hakime A.
        • Lagalla R.
        • Iannaccone R.
        • et al.
        Budd-Chiari syndrome: spectrum of imaging findings.
        AJR Am J Roentgenol. 2007; 188: W168-W176https://doi.org/10.2214/AJR.05.0168
        • Chung Y.E.
        • Kim M.J.
        • Park Y.N.
        • Choi J.Y.
        • Pyo J.Y.
        • Kim Y.C.
        • et al.
        Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation.
        Radiographics. 2009; 29: 683-700https://doi.org/10.1148/rg.293085729
        • Schöllkopf C.
        • Smedby K.E.
        • Hjalgrim H.
        • Rostgaard K.
        • Panum I.
        • Vinner L.
        • et al.
        Hepatitis C infection and risk of malignant lymphoma.
        Int J Cancer. 2008; 122: 1885-1890https://doi.org/10.1002/ijc.23416
        • Tomasian A.
        • Sandrasegaran K.
        • Elsayes K.M.
        • Shanbhogue A.
        • Shaaban A.
        • Menias C.O.
        Hematologic malignancies of the liver: spectrum of disease.
        Radiographics. 2015; 35: 71-86https://doi.org/10.1148/rg.351130008
        • Rajesh S.
        • Bansal K.
        • Sureka B.
        • Patidar Y.
        • Bihari C.
        • Arora A.
        The imaging conundrum of hepatic lymphoma revisited.
        Insights Imaging. 2015; 6: 679-692https://doi.org/10.1007/s13244-015-0437-6
        • Weissleder R.
        • Stark D.D.
        • Elizondo G.
        • et al.
        MRI of hepatic lymphoma.
        Magn Reson Imaging. 1988; 6: 675-681https://doi.org/10.1016/0730-725x(88)90092-6
        • Colagrande S.
        • Calistri L.
        • Grazzini G.
        • Nardi C.
        • Busoni S.
        • Morana G.
        • et al.
        MRI features of primary hepatic lymphoma.
        Abdom Radiol (NY). 2018; 43: 2277-2287https://doi.org/10.1007/s00261-018-1476-5
        • Ippolito D.
        • Porta M.
        • Maino C.
        • Pecorelli A.
        • Ragusi M.
        • Giandola T.
        • et al.
        Diagnostic approach in hepatic lymphoma: radiological imaging findings and literature review.
        J Cancer Res Clin Oncol. 2020; 146: 1545-1558https://doi.org/10.1007/s00432-020-03205-x
        • Semelka R.C.
        • Nimojan N.
        • Chandana S.
        • Ramalho M.
        • Palmer S.L.
        • DeMulder D.
        • et al.
        MRI features of primary rare malignancies of the liver: a report from four university centres.
        Eur Radiol. 2018; 28: 1529-1539https://doi.org/10.1007/s00330-017-5102-7
        • Sato K.
        • Takeyama Y.
        • Tanaka T.
        • Fukui Y.
        • Gonda H.
        • Suzuki R.
        Fulminant hepatic failure and hepatomegaly caused by diffuse liver metastases from small cell lung carcinoma: 2 autopsy cases.
        Respir Investig. 2013; 51: 98-102https://doi.org/10.1016/j.resinv.2012.12.004
        • Tanaka K.
        • Tomita H.
        • Hisamatsu K.
        • Hatano Y.
        • Yoshida K.
        • Hara A.
        Acute liver failure associated with diffuse hepatic infiltration of malignant melanoma of unknown primary origin.
        Intern Med. 2015; 54: 1361-1364https://doi.org/10.2169/internalmedicine.54.3428
        • Hanamornroongruang S.
        • Sangchay N.
        Acute liver failure associated with diffuse liver infiltration by metastatic breast carcinoma: a case report.
        Oncol Lett. 2013; 5: 1250-1252https://doi.org/10.3892/ol.2013.1165
        • Allison K.H.
        • Fligner C.L.
        • Parks W.T.
        Radiographically occult, diffuse intrasinusoidal hepatic metastases from primary breast carcinomas: a clinicopathologic study of 3 autopsy cases.
        Arch Pathol Lab Med. 2004; 128: 1418-1423https://doi.org/10.1043/1543-2165(2004)128<1418:RODIHM>2.0.CO;2
        • Vernuccio F.
        • Dioguardi Burgio M.
        • Barbiera F.
        • Cusmà S.
        • Badalamenti G.
        • Midiri M.
        • et al.
        CT and MR imaging of chemotherapy-induced hepatopathy.
        Abdom Radiol (NY). 2019; 44: 3312-3324https://doi.org/10.1007/s00261-019-02193-y
        • Vilgrain V.
        • Lagadec M.
        • Ronot M.
        Pitfalls in liver imaging.
        Radiology. 2016; 278: 34-51https://doi.org/10.1148/radiol.2015142576
        • Kang S.P.
        • Taddei T.
        • McLennan B.
        • Lacy J.
        Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and management.
        World J Gastroenterol. 2008; 14: 1622-1624https://doi.org/10.3748/wjg.14.1622